Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system. The clinical course of MS varies among patients. Currently, interferon (IFN) products, including IFN β-1a administered intramuscularly or subcutaneously and IFN β-1b subcutaneously, glatiramer acetate, nata...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Murphy, Julie A, Harris, Jacklyn A, Crannage, Andrew J
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2010
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2951744/
https://ncbi.nlm.nih.gov/pubmed/20957121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S3501
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky